Table 3.

Pupillometry data from stroke patients with and without strategic infarctions, and controls.

	Group 1	Group 2	Controls	p-value*	p-value**
	Stroke patients with strategic infarctions (n = 25)	Stroke patients without strategic infarctions (n = 25)	Patients with myocardial infarction (n = 25)
Npi L	4.52 ± 0.08	4.38 ± 0.08	4.42 ± 0.07	0.2	0.36
Size L (mm)	3.44 ± 0.16	3.31 ± 0.15	3.17 ± 0.17	0.55	0.24
Min L (mm)	2.33 ± 0.01	2.41 ± 0.09	2.30 ± 0.09	0.53	0.32
%Ch L	31.6 ± 1.71	26.1 ± 1.63	25.4 ± 2.07	0.03†	0.02†
CV L (mm/s)	2.09 ± 0.17	1.87 ± 0.16	1.71 ± 0.17	0.36	0.13
MCV L (mm/s)	3.39 ± 0.28	2.75 ± 0.25	2.59 ± 0.26	0.1	0.05†
DV L (mm/s)	0.88 ± 0.06	0.84 ± 0.08	0.80 ± 0.07	0.68	0.43
Lat L (s)	0.24 ± 0.01	0.24 ± 0.01	0.24 ± 0.01	0.54	0.84
Npi R	4.45 ± 0.08	4.44 ± 0.08	4.44 ± 0.07	0.99	0.94
Size R (mm)	3.34 ± 0.14	3.29 ± 0.17	3.17 ± 0.18	0.81	0.45
Min R (mm)	2.33 ± 0.09	2.35 ± 0.11	2.3 ± 0.09	0.84	0.84
%Ch R	29.4 ± 2.14	27.7 ± 1.42	25.4 ± 2.03	0.53	0.18
CV R (mm/s)	2.03 ± 0.15	2.09 ± 0.14	1.66 ± 0.17	0.74	0.12
MCV R (mm/s)	3.19 ± 0.27	3.06 ± 0.23	2.53 ± 0.24	0.88	0.11
DV R (mm/s)	0.83 ± 0.08	0.83 ± 0.06	0.84 ± 0.09	0.94	0.89
Lat R (s)	0.24 ± 0.01	0.23 ± 0.01	0.24 ± 0.01	0.33	0.97

Values are referring to mean±SEM; significance level p < 0.05; L, left; R, right; mm, millimeters; s, seconds; for other abbreviations see Table 1;

^*Group 1 vs. group 2;

^**Group 1 vs. controls;

^†No longer significant after adjustment for multiple testing (%Ch L p = 0.026, adjusted p = 0.344; p = 0.025, adjusted p = 0.333; MCV L p = 0.0461, adjusted p = 0.507).